|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-7-22
|
|
pubmed:abstractText |
Treatment failure during highly active antiretroviral therapy (HAART) is ultimately common and associated with the development of resistance mutations. Trizivir (zidovudine/lamivudine/abacavir) and tenofovir disoproxil fumarate may improve adherence and enhance virological suppression in individuals who have failed previous regimens.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0305-7453
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
186-9
|
|
pubmed:meshHeading |
pubmed-meshheading:15911551-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:15911551-Adenine,
pubmed-meshheading:15911551-Anti-HIV Agents,
pubmed-meshheading:15911551-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15911551-CD4 Lymphocyte Count,
pubmed-meshheading:15911551-Cholesterol,
pubmed-meshheading:15911551-Dideoxynucleosides,
pubmed-meshheading:15911551-Drug Combinations,
pubmed-meshheading:15911551-Erythrocyte Indices,
pubmed-meshheading:15911551-Humans,
pubmed-meshheading:15911551-Lamivudine,
pubmed-meshheading:15911551-Patient Compliance,
pubmed-meshheading:15911551-Phosphonic Acids,
pubmed-meshheading:15911551-Salvage Therapy,
pubmed-meshheading:15911551-Viral Load,
pubmed-meshheading:15911551-Viremia,
pubmed-meshheading:15911551-Zidovudine
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol.
|
|
pubmed:affiliation |
The St Stephen's Centre, The Chelsea and Westminster Hospital, London, UK.
|
|
pubmed:publicationType |
Journal Article
|
